North America Cell Sorting Market

North America Cell Sorting Market Size 

The North America Cell Sorting Market was valued at USD 82.66 million in 2023. The North America Cell Sorting Market is expected to have 7.65 % CAGR from 2024 to 2032 and be worth USD 160.48 million by 2032 from USD 88.98 million in 2024.  

North America is presently leading the global cell sorting market, accounting for more than 36% of the entire market share. The increased government funding focused on enhancing cell sorting is the prime growth driver for this region's market.

Growing research activities on developing innovative healthcare services and raising funds by private and public organizations propel the cell sorting market in North America. Y-O-Y growth in the incidence of chronic diseases such as cancer, diabetes, infectious diseases, and the rapid adoption of technology advancements further accelerates the market growth. Around 133 million Americans, i.e., 40% of the population, suffer from chronic diseases, which impel the cell sorting market in North America over the forecast period. 

Lack of awareness and shortage of skilled professionals are impeding the growth rate of the market. High expensive nature of the instruments is restraining the cell sorting market in North America. Moreover, the rise in difficulties associated with cell sorting may obstruct the market growth in the region.

This research report on the North America Cell Sorting Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment.

SEGMENTAL ANALYSIS

By Technology Insights

• FACS-based Droplet Sorting

• MACS

• Microfluidics

By Product Insights

• Cell Sorters

• Reagents

• Consumables

By Application Insights

• Research

• Clinical

By End User Insights

• Research Institutes

• Biopharma Companies

• Medical Schools

Country Level Analysis

• The United States
• Canada
• Rest of North America

Based on the region, the cell sorting market in North America is dominating globally during the review period, accounting to have 36% of the market's total share. Moreover, this region's market is attributed to massive pharmaceutical and biotechnology companies' massive investments and growing approvals for the new equipment in cancer treatment procedures. Developments in healthcare infrastructures, significant expenses made for healthcare, and intensifying government funds for research and development activities are likely to impel the cell sorting market.

The United States is forecasted to rule the North American market during the forecast period. The factors responsible for the market's growth are advancements in novel remedies and developments in healthcare infrastructure. According to the National Health Council, chronic diseases impact around 133 million Americans, which means more than 40% of the total population in the U.S. In the U.S., massive research and development activities procedures are implemented for cancer treatments, which aid the cell sorting market growth.

The Canadian market is expected to have considerable growth due to the growing patient count and an increase in the aging population.

KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE

Noteworthy Companies leading the North America Cell Sorting Market Profiled in the Report are Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sony Biotechnology, Inc. (U.S.), Sysmex Partec GmbH (Japan), Cytonome/ST, LLC (U.S.), On-Chip Biotechnologies Co., Ltd. (Japan), and Union Biometrica, Inc. (U.S.).